Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.40-1.42 (-3.86%)
At close: 4:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 356.40
52 Week Low 333.50
50-Day Moving Average 338.58
200-Day Moving Average 342.27

Share Statistics

Avg Vol (3 month) 3761.78k
Avg Vol (10 day) 3780.35k
Shares Outstanding 5142.39M
Implied Shares Outstanding 6N/A
Float 8140.92M
% Held by Insiders 11.03%
% Held by Institutions 195.68%
Shares Short (Jun 29, 2021) 46.47M
Short Ratio (Jun 29, 2021) 46.17
Short % of Float (Jun 29, 2021) 45.28%
Short % of Shares Outstanding (Jun 29, 2021) 44.54%
Shares Short (prior month May 27, 2021) 46.85M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 49.23%
Operating Margin (ttm)59.84%

Management Effectiveness

Return on Assets (ttm)16.98%
Return on Equity (ttm)259.61%

Income Statement

Revenue (ttm)331.26M
Revenue Per Share (ttm)2.43
Quarterly Revenue Growth (yoy)251.10%
Gross Profit (ttm)189.99M
EBITDA 199.78M
Net Income Avi to Common (ttm)163.08M
Diluted EPS (ttm)1.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)764.31M
Total Cash Per Share (mrq)5.37
Total Debt (mrq)878.23M
Total Debt/Equity (mrq)1,299.26
Current Ratio (mrq)8.77
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)118.59M
Levered Free Cash Flow (ttm)44.94M
Advertisement
Advertisement